UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment ...

Columnist Ben Hofmeister may rely on others for daily living, but trusting people isn't the same as giving up, he says.

Breastfeeding for longer in infancy may be associated with lower disease severity and a later onset of MS in adulthood, a study found.

After struggling during seasons when MS took center stage, columnist Ahna Crum is enjoying the quieter days where it's only ...

Immunic raised funds to support Phase 3 clinical trials of vidofludimus calcium for MS and transition into a commercial-stage company.

A collaboration will test whether changes in a person’s voice can help detect multiple sclerosis, potentially enabling a faster diagnosis.

With this year's Read-a-Thon for kids, running through March, MS Canada hopes to raise CA$65,000 to support research and community programs.

Some MS diets may help lower inflammation marker levels, but evidence from clinical trials remains limited, according to a new review paper.

MS pain is the uninvited guest you can't turn away, columnist Desiree Lama writes. Listening to your body is the key to ...

A type of immune cell targeting the Epstein-Barr virus may play a key role in driving multiple sclerosis (MS), a study found.

TG Therapeutics is gearing up for a new clinical trial, dubbed ULTIMATE, to test Briumvi in children and adolescents with ...

Tolebrutinib failed to lower disability progression risk in primary progressive MS in a Phase 3 trial, with data shown at ...